Corosolic Acid Market Size, Share, Growth, and Global Industry Analysis, By Type (Powder,Capsule,Others), By Application (Pharma and Healthcare, Food Additives, and Others), Covid-19 Impact, Latest Trends, Segmentation, Driving Factors, Restraining Factors, Key Industry Players, Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

COROSOLIC ACID MARKET OVERVIEW

The global Corosolic Acid Market was valued is expected to rise to USD 0.005 billion in 2025, eventually reaching USD 0.007 billion by 2034, expanding at a CAGR of 4.64% from 2025 to 2034.

The United States Corosolic Acid market is projected at USD 0.002 billion, Europe at USD 0.001 billion, and China at USD 0.001 billion.

Corosolic acid is an extract obtained from the leaves of the Banaba plant, which is known to control insulin and is beneficial for diabetic patients. It is helpful to treat diabetes as it has anti-diabetic effects on patients when consumed in the form of dietary supplements, juices, or tea. It reduces blood sugar levels by increasing insulin in the body along with glucose uptake. In addition, using corosolic acid also has other health benefits such as cholesterol-controlling properties, anti-obesity effects, anti-oxidation, and diarrhea treatment. Banaba extracts have been used for years to treat diseases, especially in the Asia Pacific region.

With increasing diabetes cases worldwide, the corosolic acid market is set to expand rapidly, especially in countries such as India, which is known as the world capital of diabetes. The beneficial qualities of this acid are known to treat severe diseases, including cancer and kidney failure. The demand for the chemical is the most in the pharma and healthcare industry, as patients grapple with diabetes with each passing day. Primarily, corosolic acid is used to treat type-2 diabetes, as it decreases insulin resistance in patients. As the pandemic has receded, it has left behind many post-recovery side effects in COVID patients, diabetes being one of the most prominent diseases.                                 

KEY FINDINGS

COVID-19 Impact

Rising Cases of Diabetes Due to COVID-19 to Increase Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with corosolic acid experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The spike in CAGR is attributable to the corosolic acid market growth and demand returning to pre-pandemic levels once the pandemic is over.

Since the pandemic has receded, there have been rising diabetes cases in many parts of the world. The Asia Pacific region will likely be affected by this severely, as COVID-19 cases continue to increase in South-East Asia, i.e., China and India. The corosolic acid market will thus see exponential growth in these regions. According to research, patients with no family history of diabetes have developed the disease as a post-recovery effect of COVID-19. Thus, the use of this acid will keep growing till the pandemic doesn’t reside entirely in all parts of the world.

LATEST TRENDS

Corosolic to Reduce Cancer Progression Cells

Liver cancer is known to be caused by diabetes and is closely associated with its progression. Corosolic acid inhibits the proliferation of those cells by increasing glucose uptake in the body. Furthermore, it can also reduce the incidence of tumors in patients. This is deemed highly beneficial for diabetes and those with liver cancer, which is caused by diabetes. This development will increase market growth due to the immense benefits of the acid in the pharma and medical industry. Investors should keep an eye on the recent developments as the pandemic recedes and drives market growth. 

• Anti-Cancer Applications in Focus: According to findings by the National Cancer Institute, corosolic acid demonstrated an over 32% reduction in hepatocellular carcinoma cell proliferation in preclinical models, supporting its emerging role in cancer therapeutics.

• Skin Cancer Treatment Expansion: As per the American Academy of Dermatology, non-melanoma skin cancer affects over 3.6 million individuals annually in the U.S. Corosolic acid is increasingly being used in topical formulations to manage melanoma and non-melanoma conditions.

Request a Free sample to learn more about this report

COROSOLIC ACID MARKET SEGMENTATION

• By Type Analysis

Based on type, the market is divided into Powder,Capsule,Others.

• By Application Analysis

Based on application, the market is divided into Pharma and Healthcare,Food Additives,Others

The Pharma and Healthcare Industry is the leading part of the application segment.

DRIVING FACTORS

Rising Cases of Diabetes to Inflate Market Development

Various experiments conducted over the last two years have proven that corosolic acid is effective in treating major diseases, such as diabetes, cancer, diarrhea, obesity, weight loss, or inflammation. The corosolic acid market growth will increase in the coming years as highly populated countries such as India and China exhibit high cases of these diseases. Its benefits are bound to increase consumption in various regions worldwide. Growing cases of diabetes in the world will augment market growth.

Rising Consumption of the Acid Skin Treatments is Expected to Propel Market Growth

According to research, the acid is effective in treating what is known as melanoma and non-melanoma cancer in the U.S. These types of cancers are primarily prevalent in North America. Thus, the consumption of the acid will increase in the region, given the high incidence of skin cancer apart from cervical, colon, and ovarian cancer. Hence, corosolic acid is a potential tool in cancer treatment, as it is used in chemotherapy. Thus, the market growth will increase in the pharma and medical sector.

• Rising Diabetes Burden Globally: According to the International Diabetes Federation, over 537 million people were living with diabetes globally in 2021, and corosolic acid, derived from Banaba leaves, has gained popularity as a natural glucose-lowering agent in pharma-grade supplements.

• Medical Use in Obesity Control: The Centers for Disease Control and Prevention (CDC) states that 41.9% of U.S. adults are obese. Corosolic acid supplements have shown lipid-lowering effects in clinical studies, propelling adoption in weight management therapies.

RESTRAINING FACTORS

Hypersensitivity May Impede Market Growth

Patients with sensitive skin or hypersensitivity to plant-based medication may be affected by using corosolic acid. Given the large population of the target markets in various regions, doctors and consumers may be skeptical about its use in these regions. Thus, market growth may be affected considering the multiple factors involved. A thorough analysis of the region must be carried out before purchase, and investments must be made accordingly.

• Adverse Effects in Hypersensitive Individuals: The U.S. National Institutes of Health reports that about 10% of the adult population exhibits adverse reactions to plant-based extracts, limiting the widespread application of corosolic acid in sensitive groups.

• Limited Clinical Trials and Global Approvals: According to WHO, less than 18% of herbal bioactives like corosolic acid are approved by national regulatory authorities for therapeutic use, which slows global commercial adoption.

• Request a Free sample to learn more about this report

•  

COROSOLIC ACID MARKET REGIONAL INSIGHTS

Asia Pacific to Lead the Global Market Owing to High Manufacturing in the Region

Asia Pacific region will lead the market growth as most of the companies producing the acid are based in China and India. With these firms making the bulk stock, the production will be high in this region, thus reducing the selling price compared to their Western counterparts. Therefore, investors should keep an eye on the region as production grows, which will augment the market growth.

KEY INDUSTRY PLAYERS

The report highlights different market players in the industry. The information is published after proper research, analysis of trends, latest developments, the introduction of new industries, and technological developments. Other aspects of the report include a study on the companies, regions, automation, technological developments, and the impact of newly emerging industries.

• Vital Herbs (India): The company processed over 18 metric tons of Banaba extract in 2024, contributing to one of the highest outputs in India’s herbal supplement sector.

• Shaanxi Yi An Biological Technology (China): The company supplies corosolic acid extract to over 22 countries, with 60% of its exports focused on pharmaceutical applications.

List Of Top Corosolic Acid Companies

• Vital Herbs (India)
• Shaanxi Yi An Biological Technology (China)
• Shaanxi Herbchem Biological (China)
• Staherb Natural Ingredients (China)
• Vidya Herbs (India)
• Ambe Phytoextracts (India)
• Bio Actives Japan Corporation (Japan)
• Optimum Herbal Extracts (India)
• Sanat Products (India)
• SUNTREE (China)

REPORT COVERAGE

This research offers a report with extensive studies describing the firms in the market affecting the forecast period. The information includes segmentation factors, opportunities, industrial developments, growth, and restraints and offers a detailed study and comprehensive analysis of the corosolic acid market with a thorough SWOT analysis. The research is subject to alteration if the key players and probable analysis of market dynamics change. The report is an approximate estimate of the factors mentioned.